Cerebras Systems · 2026-05-04 · major
Cerebras Bumps IPO Range to $150–160 — $4.8B Raise at up to $48.8B as Demand Tops 20x; Nasdaq Pricing Slated May 14
After ~20x oversubscription, Cerebras lifted its Nasdaq IPO range to $150–$160/share from $115–$125 and is now targeting up to $4.8B in proceeds at a fully-diluted valuation as high as $48.8B. Pricing is expected May 14 under CBRS.
Cerebras lifts its Nasdaq IPO range to $150–$160 from $115–$125 as books run ~20x oversubscribed; valuation now reaches $48.8B.
Key specs
| Raise | up to $4.8B |
|---|---|
| Valuation | up to $48.8B |
| Shares | 28M |
| Price range | $150–$160 |
| Original price range | $115–$125 |
| Demand multiple | ~20x |
| Ticker | CBRS |
| Exchange | Nasdaq |
| Expected pricing | 2026-05-14 |
What is it?
Cerebras Systems makes wafer-scale AI accelerators — chips the size of a dinner plate that pack hundreds of thousands of cores onto a single piece of silicon, sold mainly as inference clusters. The company filed an updated S-1 on May 4 to open its Nasdaq roadshow under ticker CBRS. After a week of marketing, Reuters, CNBC, and Bloomberg all reported on May 10–11 that the underwriters are lifting the price range and target raise to match the demand.
How does it work?
The amended terms cover 28 million Class A shares at $150–$160 (up from $115–$125), implying gross proceeds up to ~$4.8B and a fully-diluted valuation as high as $48.8B — roughly double the February 2026 mark and well above the prior $26.6B target. Reporting cites ~20x oversubscription with Morgan Stanley, Citigroup, Barclays, and UBS leading the book. Nasdaq is now expected to price the deal on May 14, with first trades the next day. The S-1 still discloses ~$510M in 2025 revenue and a ~$1B loan from OpenAI secured by warrants on 33M Cerebras shares.
Why does it matter?
A bump of this magnitude makes Cerebras the largest pure-play AI-hardware IPO of the year and one of the largest tech listings since the post-2022 reset. It also resets the public comparable for inference-only chip vendors like Groq, Tenstorrent, and Etched almost overnight. If the deal trades well, expect the OpenAI-style loan-and-warrant supply financing to spread, and expect every AI-infra startup with an S-1 in the drawer to pull it forward.
Who is it for?
infra investors, AI-chip watchers, OpenAI ecosystem analysts
Try it
Track CBRS pricing via Nasdaq's IPO calendar for May 14, 2026